On April 15, 2026, the Minnesota Pollution Control Agency (MPCA) announced a second extension of the initial PFAS products reporting deadline, moving it from July 1, 2026 to September 15, 2026. Upon completion of the initial report, subsequent annual reports are due each February 1. Manufacturers unable to meet the deadline may apply for a single 90-day extension (to December 14, 2026).
On April 15, 2026, the National Institutes for Food and Drug Control (NIFDC) published six technical guidelines regaeding hair dye, perm and sunscreen cosmetics. The promulgation and implementation of the above technical guidelines provide normative technical basis for the study and quality control of above three kinds of cosmetics.
On April 3, 2026, the Korean Ministry of Food and Drug Safety (MFDS) announced that, in response to packaging material supply shortages, it would temporarily allow food, cosmetics, and other products to display required labeling information using sticker labels when using alternative packaging materials. This temporary measure takes effect on April 5 and will be valid for six months (may be terminated early or extended depending on actual supply conditions).
On April 2, 2026, the Korea Cosmetic Association (KCIA) issued an announcement stating that the Ministry of Food and Drug Safety (MFDS) partially amended the Enforcement Rule of the Cosmetics Act on March 31, 2026, aiming to further strengthen the safety supervision of directly purchased overseas cosmetics. The amended provisions have entered into force on April 2, 2026.
In March 2026, the Shanghai Municipal, Fujian Provincial, Hubei Provincial, and Anhui Provincial Medical Products Administrations successively issued announcements regarding cosmetic supervision and sampling inspections. A total of 12 batches of products were found to be non-compliant. This summary of the announcements aims to help enterprises stay informed of evolving regulatory trends and strengthen their quality management and compliance awareness.
On March 31, 2026, China’s National Medical Products Administration (NMPA) issued the Announcement on Matters Related to Cosmetic Registration and Filing (Draft for Comments) and is now soliciting public comments.
Globally, the regulatory landscape for exosome cosmetics exhibits significant variability. This article systematically reviews the management measures, regulations, and ethical standards concerning exosome cosmetics in various countries/regions, including the United States, the European Union, Japan, South Korea, Taiwan, and mainland China. It explores the context of compliance and prohibitions, as well as their impact on industry development, providing comprehensive global regulatory compliance guidance for cosmetic companies.
On March 11, 2026, the U.S. Food and Drug Administration (FDA) launched a new unified platform for analyzing adverse event reports, known as the FDA Adverse Event Monitoring System (AEMS). This initiative marks a significant milestone in the agency’s mission to modernize and enhance transparency regarding the safety of regulated products.On March 11, 2026, the U.S. Food and Drug Administration (FDA) launched a new unified platform for analyzing adverse event reports, known as the FDA Adverse Event Monitoring System (AEMS). This initiative marks a significant milestone in the agency’s mission to modernize and enhance transparency regarding the safety of regulated products.
The following FAQs are all related to ordinary cosmetics filing, CIRS Group has compiled the information and translated it into English for your reference.
Based on data retrieved from China’s National Medical Products Administration (NMPA), nine new cosmetic ingredients have been filed between March 1 and March 12, 2026. Detailed information is provided in the table below. At present, the associated technical specifications have not been made public, and the ingredient has not yet entered the post-filing monitoring period. As of now in 2026, a total of 45 new cosmetic ingredients have been filed.
